跳至主要内容
临床试验/NCT04051567
NCT04051567Unknown4 期

Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies--A Multicenter, Prospective, Open, Randomized, Controlled Clinical Trial

Ministry of Science and Technology of the People´s Republic of China1 个研究点 分布在 1 个国家目标入组 425 人开始时间: 2018年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
425
试验地点
1
主要终点
The incidence of preeclampsia, preterm birth, fetal growth restriction

研究概览

简要总结

Twin pregnancies are associated with increased risk of perinatal adverse outcomes , including preeclampsia , fetal growth restriction , preterm premature rupture of membranes and preterm birth. Low-dose aspirin was recommend by American College of Obstetricians and Gynecologists (ACOG) during pregnancy. In this trial, the investigators suppose that aspirin used in twin-pregnancies could improve adverse pregnancy outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Twin pregnancy diagnosed by ultrasound and maternal age ranged from 18 to 55 years, Gestational age was less than 16w

排除标准

  • Diagnosed fetal anomalies, history of cervical cerclage, contraindications of aspirin, pre-existing renal or liver diseases or abnormal functions, coagulation disorders, history of PE, preterm birth or FGR, chronic hypertension

研究组 & 干预措施

LDA group

Experimental

干预措施: Aspirin 100mg (Drug)

结局指标

主要结局

The incidence of preeclampsia, preterm birth, fetal growth restriction

时间窗: after 30 weeks of gestional age

次要结局

未报告次要终点

研究者

发起方
Ministry of Science and Technology of the People´s Republic of China
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Hongbo Qi

Professor

Ministry of Science and Technology of the People´s Republic of China

研究点 (1)

Loading locations...

相似试验